Guangzhou LBP Medicine Science & Technology Co., Ltd.

SHSE:688393 Stock Report

Market Cap: CN¥1.8b

Guangzhou LBP Medicine Science & Technology Past Earnings Performance

Past criteria checks 4/6

Guangzhou LBP Medicine Science & Technology's earnings have been declining at an average annual rate of -21.5%, while the Medical Equipment industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 5.1% per year. Guangzhou LBP Medicine Science & Technology's return on equity is 2%, and it has net margins of 7.9%.

Key information

-21.5%

Earnings growth rate

-28.6%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate5.1%
Return on equity2.0%
Net Margin7.9%
Last Earnings Update31 Mar 2024

Recent past performance updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Apr 23
Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Mar 09
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Revenue & Expenses Breakdown
Beta

How Guangzhou LBP Medicine Science & Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688393 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 245084026759
31 Dec 234974026063
30 Sep 234883726365
30 Jun 234762627464
31 Mar 234783127265
31 Dec 225074326567
30 Sep 224864926558
30 Jun 224696424562
31 Mar 224607323755
31 Dec 214398023446
30 Sep 214389322945
30 Jun 2144310322932
31 Mar 2143610222230
31 Dec 203758519228
30 Sep 203708018526
30 Jun 203447517225
31 Mar 203236817123
31 Dec 193557419022
31 Dec 183066116516
31 Dec 172604814215
31 Dec 1314338570

Quality Earnings: 688393 has high quality earnings.

Growing Profit Margin: 688393's current net profit margins (7.9%) are higher than last year (6.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688393's earnings have declined by 21.5% per year over the past 5 years.

Accelerating Growth: 688393's earnings growth over the past year (30.2%) exceeds its 5-year average (-21.5% per year).

Earnings vs Industry: 688393 earnings growth over the past year (30.2%) exceeded the Medical Equipment industry -1.4%.


Return on Equity

High ROE: 688393's Return on Equity (2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.